Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 256-264
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.256
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.256
Group | n | Tch (mmol/L) | TG (mmol/L) | ALT (IU) | AST (IU) |
Control | 10 | 1.88 ± 0.42 | 1.09 ± 0.42 | 6.26 ± 2.76 | 8.15 ± 3.70 |
Fatty liver | 39 | 3.36 ± 1.43a | 1.69 ± 1.12a | 27.48 ± 21.64a | 22.87 ± 17.51a |
Degeneration | 17 | 6.26 ± 1.79a | 4.51 ± 3.10a | 54.45 ± 33.82a | 35.09 ± 14.72a |
Precancerous | 15 | 4.84 ± 1.37a | 4.68 ± 2.20a | 48.83 ± 29.30a | 50.38 ± 22.65a |
Cancerous | 10 | 5.10 ± 1.18a | 3.10 ± 1.76a | 32.97 ± 21.34a | 31.41 ± 16.13a |
- Citation: Gu JJ, Yao M, Yang J, Cai Y, Zheng WJ, Wang L, Yao DB, Yao DF. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. World J Gastroenterol 2017; 23(2): 256-264
- URL: https://www.wjgnet.com/1007-9327/full/v23/i2/256.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i2.256